Breast Cancer Screening
Making Sense of Complex and Evolving Evidence

This insightful book provides a balanced perspective on the increasingly controversial topic of breast cancer screening, with a focus on current and emerging scientific evidence as well as look at such future breast cancer screening practices as tailored screening and shared decision-making plus variability in screening practice and outcomes around the world

Nehmat Houssami (Author), Diana Miglioretti (Author)

9780128022092

Hardback, published 6 April 2016

456 pages, c. 50 illustrations
23.4 x 19 x 2.8 cm, 1.04 kg

"By including studies and recommendations from around the world as well as potential benefits and harms, they have provided a valuable resource for patients, healthcare providers, and public health advocates. Score: 79 - 3 Stars" --Doody's

Approx.434 pages

1. Foreword: Breast Cancer Screening: A focus on the evidence2. Breast Cancer Screening: balancing evidence with culture, politics, money, and media3. Estimates of Screening Benefit: The Randomized Trials of Breast Cancer Screening4. Weighing the benefits and harms: Screening mammography in the balance5. The Importance of Observational Evidence to Estimate and Monitor Mortality Reduction from Current Breast Cancer Screening6. The role of microsimulation modeling in evaluating the outcomes and effect of screening7. Challenges in understanding and quantifying over-diagnosis and over-treatment8. Challenges and opportunities in the implementation of risk-based screening for breast cancer9. Breast Cancer Screening in the Older Woman10. Screening Women in their Forties11. Screening for Breast Cancer in Women with Dense Breasts12. Screening women with known or suspected cancer gene mutations13. Imaging Surveillance of Women with a Personal History of Breast Cancer14. Evolution of mammography screening: from film screen to digital breast tomosynthesis15. Ethical and Societal Considerations in Breast Cancer Screening16. Treatment of screen-detected breast cancer: can we avoid or minimize over-treatment?17. Informed and shared decision-making in breast screening

Subject Areas: Oncology [MJCL], Medical screening [MBNC]